Liquidia Technologies, the Morrisville-based nanotechnology firm, recently announced the close of a $10M investment from the Bill and Melinda Gates Foundation. The investment dollars will help Liquidia develop vaccines for influenza and malaria. Liquidia partnered in the global PATH Malaria Vaccine Initiative less than a month ago.
Liquidia is a long time CED member and supporter of the local community. Neal Fowler, CEO of Liquidia, spoke at CED’s Biotech Conference in February; he was also honored as an award winner at CED’s NC Companies to Watch event in 2010.
Liquidia currently has 54 employees in the Triangle area.
Read the full TBJ article here